January 3, 2023
The University of Cincinnati's Eva Mistry is leading a new study with funding support from the Patient-Centered Outcomes Research Institute that will examine the effectiveness of a stroke treatment for patients with a pre-stroke disability, one of the first studies to focus on this population.
September 15, 2022
The University of Cincinnati Gardner Neuroscience Institute is transforming into a Learning Health System, a data-driven, patient-centered approach with the goal of measurably improving outcomes for patients with neurological disorders.
June 3, 2022
The University of Cincinnati's Jensine' Clark and Emily Nurre lead transition clinics that help guide patients with childhood-onset disabilities and epilepsy from pediatric to adult care.
October 30, 2023
The University of Cincinnati Gardner Neuroscience Institute has been renewed as the National Coordinating Center of the National Institutes of Health StrokeNet, overseeing all NIH-funded adult and pediatric stroke trials nationwide.
October 27, 2023
A new large-scale study led by researchers at the University of Cincinnati and Northwell Health found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
November 13, 2023
A new clinical trial underway at the UC Gardner Neuroscience Institute is applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.
December 7, 2023
The UC Gardner Neuroscience Institute has received $19 million in federal funding from the National Institutes of Health to serve as the lead center for a Phase 2 clinical trial that will study the efficacy of a new monoclonal antibody treatment for patients ineligible for currently available treatments.
February 7, 2024
University of Cincinnati neurology experts are presenting research at the International Stroke Conference 2024, Feb. 7-9 in Phoenix, Arizona.
March 18, 2024
An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
May 1, 2024
Researchers at the University of Cincinnati and Dell Medical School at the University of Texas at Austin are leading a study using state-of-the-art neuroimaging techniques and artificial intelligence to identify changes in the brains among children of adults living with bipolar disorder.